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Background and Aims: Ascites and spontaneous bacterial peritonitis (SBP) are
frequent complications of liver cirrhosis. In spite of the clinical impact, knowledge about
ascites as an immune cell compartment in liver disease is limited. Therefore, we analyzed
NK cells in blood, ascites, and liver.
Methods: Mononuclear cells from blood, ascites, and liver explants of patients with
advanced liver disease were extracted by density gradient centrifugation. Phenotyping
and analysis of functional responses were carried out using flow cytometry. Migratory
potential was investigated with transwell chamber assays. NK cell metabolism was
assessed by Seahorse technology.
Results: NK cell frequency was increased in uninfected ascites compared to blood, but
not to liver. Ascites NK cells were predominantly CD16positive. CD56bright ascites NK cells
did not share the typical phenotype of their liver counterparts. In contrast to the inhibitory
receptor NKG2A, expression of the activating receptor NKG2Dwas decreased on ascites
and liver CD16positive NK cells. Ascites NK cells expressed higher levels of CXCR3 than
blood or liver NK cells, corresponding to increased ascites levels of CXCL10. Blood NK
cells migrated toward ascites. Stimulation of mononuclear cells with Escherichia coli
led to downregulation of NKG2D expression and IL-12 and IL-18 mediated secretion
of interferon-γ by ascites and liver, but not blood NK cells. In-vivo, ascites NK cells
expressed higher levels of the activation marker CD69 and lower levels of NKG2D during
SBP compared to uninfected ascites.
Conclusion: Ascites NK cells display a particular phenotype and are implicated in local
immune defense against translocating bacteria.
Keywords: ascites, Escherichia coli, liver, lymphocyte, NK cells, peritoneal cavity, spontaneous bacterial
peritonitis
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INTRODUCTION
Despite advances in medical treatment, bacterial peritonitis
is still a life-threatening infection. This applies in particular
to patients with liver cirrhosis, who are highly susceptible
to spontaneous bacterial peritonitis (SBP) caused by bacterial
translocation from the intestine (1). In cirrhotic patients,
the peritoneal cavity is therefore not only an immunological
compartment of interest, but also accessible for research, because
these patients often develop ascites and require paracentesis.
Ascites, which contains peritoneal immune cells, comprises
mainly monocytes/macrophages, which are seen as primary line
of defense against bacteria, and lymphocytes (2). Neutrophil
numbers rise only during bacterial peritonitis to significant
levels, which makes a neutrophil count >250 cells/µL a reliable
diagnostic marker for bacterial peritonitis (1). Murine studies
indicate that also lymphocytes, in particular NK cells, play an
important role in bacterial peritonitis (3, 4). However, a potential
involvement of human NK cells in peritoneal antibacterial
defense has not been investigated. Taking advantage of the
accessibility of NK cells from different tissues in patients with
liver cirrhosis, we hypothesized that ascites NK cells may differ
concerning phenotype and function from NK cells from other
relevant tissues such as liver and blood and that they take part
in antibacterial response.
PATIENTS AND METHODS
Patients
Patients with decompensated liver cirrhosis were included in
this study if they were at least 18 years old and had given
informed consent. Diagnosis of liver cirrhosis was based on liver
histology or on clear evidence of portal hypertension by clinical,
laboratory, and radiological findings in presence of chronic
liver disease. When patients received a diagnostic or therapeutic
paracentesis, ascites, and blood were collected. In patients
undergoing liver transplant, a slice of explanted liver tissue was
processed as described below. Paracentesis was performed and
SBP was diagnosed according to international guidelines (1).
Demographical, clinical, and standard laboratory data of the
patients were retrieved from the medical records. The study was
approved by the local ethics committee (HBRC 16-261).
Two cohorts of patients were analyzed (Table 1). In a first
cohort (tissue cohort), liver, ascites and blood samples from
patients without SBP (n = 43) were collected to investigate
differences between these tissues. To assess the impact of SBP
on NK cell phenotype, ascites samples with (n = 8) and without
SBP (n= 15) from a second cohort (SBP cohort) were compared.
Samples are from patients without SBP unless otherwise stated.
Methods
Isolation of Peripheral Blood Mononuclear Cells
(PMBC), Ascites Mononuclear Cells (AMC), and Liver
Infiltrating Mononuclear Cells (LMC)
Venous bloodwas collected in EDTA tubes. Up to 1l of ascites was
collected in sterile culture flasks. PBMC and LMC were isolated
as described previously (5). After centrifuging ascites for 10min
TABLE 1 | Patient characteristics.
Tissue cohort SBP cohort
Without SBP With SBP
Patients [n] 43 15 8
SBP samples [n] 0 0 8
Male sex [n, %] 32 (74%) 10 (67%) 5 (63%)
Age [years] 53 (45; 65) 54 (56; 67) 67 (57; 71)
Etiology of liver cirrhosis [n, %]
- Alcohol 22 (51%) 11 (73%) 3 (37%)
- NAFLD 4 (9%) – –
- PBC 4 (9%) – –
- PSC 6 (14%) – –
- Cryptogenic 1 (2%) 2 (13%) 1 (13%)
- Other* 6 (14%) 2 (13%) 4 (50%)
MELD score [points] 14 (12; 18) 14 (12; 18) 21 (19; 28)
Serum albumin [g/L] 33 (31; 37) 29 (26; 34) 29 (23; 33)
Ascites PMN [/µL] 40 (9; 95) 36 (9; 52) 847 (264; 3953)
Ascites total protein [g/L] 19 (11; 22) 11 (6; 18) 11 (5; 16)
Culture positive ascites 0 0 5 (63%)
Serum LBP [µg/mL] 2.4 (1.0; 3.3) – –
Ascites samples [n] 18 15 8
Blood samples [n] 15 – –
Liver samples [n] 26 – –
Data are given as absolute numbers [%] or median (interquartiles). MELD, model for
end-stage liver disease; NAFLD, non-alcoholic fatty liver disease; PBS, primary biliary
cholangitis; PSC, primary sclerosing cholangitis. *including α1-antitrypsin deficiency,
hemochromatosis, toxic, vascular, Wilsons’s disease.
at 2,000 rpm, the cell pellet was resuspended in an appropriate
volume of ascites supernatant. AMC were separated by density
gradient centrifugation using Lympholyte (Cedarlane) or Ficoll-
Paque (Biochrom AG, Berlin, Germany). Cells from the tissue
cohort were washed twice in PBS, counted and used immediately
for experiments comparing different tissues. Cells from the SBP
cohort were stored at−150◦C until analysis. Because, as expected
in research on different kinds of human diseased tissue, the
number of cells available for experiments differed between tissues
and donors, it was not possible to provide equal numbers of
staining/experiments for all three tissues and all markers.
Analysis of Mononuclear Cells From Different Tissues
by Flow Cytometry
Expression of surface and intracellular markers was analyzed by
flow cytometry. Briefly, cells were stained with e506 viability dye
(eBiosience) for later exclusion of dead cells for 30min at 4◦C
in PBS. After washing with 2% fetal calf serum (FCS, Sigma-
Aldrich), cells were incubated on ice in the presence of antibodies
against the respective surface markers at the appropriate dilution
in 2% FCS for 30min. After washing with 2% FCS, the cells
were either fixed for 10min in 3% formaldehyde solution (Sigma-
Aldrich) or fixed and permeabilised for 45min at 4◦C with
the Foxp3/Transcription Factor Staining Buffer Set (eBioscience)
to allow staining for intracellular antigens. Together with
appropriate compensation controls (anti-mouse IgGκ /negative
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control compensation particles, BD Biosciences), data were
acquired on a CyAN ADP or BD Canto II flow cytometer.
Details on the antibodies used in this study are given in
Supplementary Table 1. NK cells were identified as viable, single
cells within the lymphocyte region in the forward/side scatter
plot expressing CD56, but not CD3 (general gating strategy and
exemplary representative dots plots in Supplementary Figure 1).
Enrichment of NK Cells
NK cells were magnetically enriched using the EasySepTM
Human NK Cell Isolation Kit (Stemcell Technologies) according
to the protocol provided by the manufacturer. NK cell purity >
90% was achieved.
Cell Stimulation With Escherichia coli
E. coli DH5α (Invitrogen) were grown in LB broth overnight,
washed twice in sterile PBS, fixed with 2% formaldehyde solution
for 30min and washed again twice in sterile PBS (6). For cell
stimulation experiments, 0.5 × 106 mononuclear cells in RPMI-
1640 medium containing penicillin (100 IU/mL), streptomycin
(100 IU/mL), glutamine (2mM) (GIBCO, Carlsbad,CA, USA),
and 10% FCS were incubated at a 1:10 ratio with fixed bacteria
for 18 h in a 24 well plate at 37◦C and 5% CO2-in-air. For
analysis of cytokine production, brefeldin A was added at a
final concentration of 5µg/mL for the last 4 h of incubation.
Finally, the cells were collected and stained as indicated above
for flow cytometry. Intracellular staining was carried out after
fixation with 3% formaldehyde solution by incubating the cells
in 0.1% saponin solution containing the antibodies of interest for
30min. For some functional experiments, blocking antibodies or
the appropriate isotype controls were added, using the following
antibodies: anti-IL12p70 (clone #24910, R&D), anti-IL18 (clone
125-2H, MBL), and anti-IFN-γ (clone B27, Biolegend) at final
concentrations of 5µg/mL, 5µg/mL, and 10 µ/mL, respectively.
Cell Migration Experiments
Wells were prepared with RPMI-1640 medium as a negative
control, ascites supernatant, or plasma. PBMC isolated from
haemochromatosis patients, who are suitable donors for control
PBMC because these patients have to undergo therapeutic
phlebotomy on a regular basis, but are in stable condition,
were added into the top chamber of 3µm transwell inserts
(Corning, Sigma-Aldrich) in RPMI. In some experiments, PBMC
were pre-incubated with a CXCR3 blocking antibody (clone
G025H7, Biolegend) at 10µg/mL, an appropriate isotype control
or pertussis toxin (100 ng/mL) for 30min. The plates were
incubated for 4 h at 37◦C and 5% CO2-in-air. Then, the fluid
in the lower chamber was collected. Cells were stained with
anti-CD3 and anti-CD56 as described above and analyzed by
flow cytometry using AccuCheck counting beads (Thermo Fisher
Scientific) for quantification.
CD107a Assay
AMCwere incubated as described above at a 1:10 ratio with fixed
E. coli in the presence of anti-CD107a antibodies (clone H4A3,
BD Biosciences) for 5 h, adding GolgiStop as recommended by
the manufacturer (BD Biosciences) after the first hour. After
staining, cells were then analyzed by flow cytometry.
Analysis of NK Cell Metabolism
Extracellular flux analysis of purified NK cells was performed
using the Seahorse XF analyzer (Agilent). Cells were initially
resuspended in XF assay media (Agilent) supplemented with
5.5mM glucose and 1mM pyruvate. 2 × 105 NK cells were
seeded onto a Cell-Tak (Corning) coated microplate. The oxygen
consumption rate (OCR; pmoles/min) was measured during
the mitochondrial stress assay with use of real-time injections;
oligomycin (1µM), carbonyl cyanide-4-(trifluoromethoxy)
phenylhydrazone (FCCP; 1µM) and rotenone/antimycin A
(both 1µM) (both from Sigma-Aldrich).
LBP ELISA and Luminex Assay
Blood or ascites were collected in serum tubes, centrifuged for
10min at 1,300 × g and supernatant was stored in aliquots
at −80◦C. LBP levels were determined using the human LBP
Duoset ELISA kit from R&D. In 8 matched pairs of serum and
ascites from the same patients, 27 cytokines were measured by
the Bio-Plex ProTM Human Cytokine 27-plex assay (Bio-Rad).
Both assays were used according to the instructions given by
the manufacturer.
Analysis of Data and Statistical Analysis
Flow cytometry data were analyzed with FlowJo (Tree Star).
Prism 7 (Graphpad) was used for graphical presentation of the
data. Statistical analyses were performedwith SPSS (IBM) version
22. Fisher’s exact test, Mann-Whitney-U-test, Wilcoxon signed-
rank test, and Kruskal-Wallis test with Bonferroni correction
were used as appropriate.
RESULTS
NK Cell Frequency Is Increased in Ascites
Comparing the relative frequency of T-, B-, NK-, and NK-
like T-cells (Figure 1A), of CD4-, CD8-, mucosal invariant T-
cells (MAIT), γδ T-cells (Figure 1B), and T regulatory cells
(Figure 1C) between ascites, peripheral blood and liver, we
detected a significantly higher proportion of NK cells among
lymphocytes in ascites and liver compared to blood. Therefore,
we focused our further analysis on NK cells.
Ascites NK Cells Are Phenotypically
Different
CD56brightCD16negative vs. CD16positive NK cells constitute the
main NK cell subsets (Figure 1D). Ascites NK cells were
predominantly CD16positive (Figure 1E). CD56bright NK cells
from the liver express the transcription factor Eomes, but not
Tbet (7). This phenotype was of intermediate frequency in ascites
compared to liver and blood (Figure 1F).
Comparing typical NK cells markers, we found that NK cells
from ascites show a particular expression pattern compared
to liver and blood. While CD16positive NK cells from ascites
and liver expressed less of the activating receptor NKG2D
in comparison to blood CD16positive NK cells (Figure 2A and
Supplementary Figure 2A), the inhibitory receptor NKG2A was
found more frequently on ascites than liver CD16positive NK
cells (Figure 2B). A higher degree of activation in CD16positive
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FIGURE 1 | Frequency of lymphocyte-subsets in different tissues. (A) T cells (CD3+); B cells (CD19+), NK cells (CD3−CD56+), and NK-like T-cells (CD3+CD56+) (n
= 9–21); (B) T cell subsets: CD4T cells (CD3+CD4+), CD8T Cells (CD3+CD8+) (n = 11–18); mucosal associated invariant T (MAIT) cells (CD3+CD161++TCR
Vα7.2+), γδ T-cells (CD3+TCR γδ+) (n = 3–4); (C) T regulatory (reg) cells (CD3+CD4+CD25highCD127low) (n = 9–13); (D) representative flow cytometry plot showing
the gating of the NK cell subsets; (E) frequency of the major NK cell subsets CD56brightCD16negative vs. CD16positive (n = 16–21); (F) frequency of the EomeshiTbetlo
phenotype (n = 6–10); *p < 0.05; **p < 0.005.
NK cells from ascites and liver was indicated by increased
HLA-DR expression compared to blood (Figure 2C and
Supplementary Figure 2B). With respect to expression of CD69
(Figure 2D) and the activating receptor NKR2B4 (Figure 2E),
CD56bright NK cells from the ascites and blood showed
comparably low levels of expression, in contrast to the liver.
The cytotoxic molecule granulysin was lower in ascites and liver
NK cells compared to blood for both NK cell subsets, with liver
CD56bright NK cells displaying the lowest expression (Figure 2F).
Expression of NKp46 did not differ between the tissues and
the maturation marker CD27 was expressed at comparatively
low levels among NK cells, with only liver CD56bright NK
cells tending to display higher expression levels (data not
shown). Analysis of mean fluorescence intensity (MFI) levels of
these markers led to similar results (Supplementary Figure 3).
Taken together, subset composition and expression of typical
markers is different in NK cells from ascites compared to liver
and blood.
Ascites NK Cells Express CD103 and High
Levels of CXCR3
Because proliferation of NK cells was similar in the three
compartments (Supplementary Figure 4), we analyzed tissue
homing markers on NK cells to understand the higher frequency
seen in ascites. High expression of CXCR6 (Figure 3A) and
CD161 (Figure 3B), but low expression of CD49e (Figure 3C)
have been reported for liver CD56bright NK cells in contrast
to blood NK cells (8, 9), but were not found in ascites.
The chemokine receptor CXCR3, though, was observed
more frequently on ascites NK cells compared to liver
and blood (Figure 3D and Supplementary Figure 2C).
In addition, expression of the integrin CD103 was
increased on ascites CD16positive NK Cells (Figure 3E and
Supplementary Figure 2D). Sphingosine 1 phosphate receptor
(S1PR) subtype 5 has been suggested as a homing marker on
CD16positive NK cells (10), but was not detected on NK cells
from any of the three tissues (data not shown). S1PR1 was
expressed mainly on liver NK cells (Figure 3F). Analysis of
MFI levels of these homing markers revealed similar results
(Supplementary Figure 5). Corresponding to the increased
CXCR3 expression levels of ascites NK cells, we found increased
levels of its ligand CXCL10 in ascites compared to matched
blood (Figure 4A). These results suggest that enrichment of
CD16positive NK cells in ascites may be related to homing integrin
CD103 and chemokine receptor CXCR3.
NK Cells Migrate Preferentially Toward
Ascites
To corroborate our phenotypic findings, we performedmigration
experiments with control PBMC from hemochromatosis patients
vs. ascites compared to plasma. As expected, more cells migrated
vs. plasma or ascites than medium (Figure 4B). However, NK
cells were enriched among PBMC that migrated vs. ascites
compared to plasma (Figure 4C). Blocking CXCR3 before the
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FIGURE 2 | Phenotype of NK cells from different tissues. (A) NKG2D (n = 9–13); (B) NKG2A (n = 10–12); (C) HLA-DR (n = 7–10); (D) CD69 (n = 4–9); (E) NKR2B4
(n = 6 each); (F) Granulysin (n = 7–10); *p < 0.05; **p < 0.005.
FIGURE 3 | Expression of tissue homing receptors on NK cells. (A) CXCR6 (n = 4–7); (B) CD161 (n = 4–6); (C) CD49e (n = 2–5); (D) CXCR3 (n = 12–14); (E) CD103
(n = 6–7); (F) S1PR1 (n = 3–5); *p < 0.05; **p < 0.005.
migration assay reduced the number of NK cells migrating
toward ascites (Figure 4D), suggesting that the CXCR3-CXCL10
axis is involved in the migration of NK cells to the ascites.
However, pertussis toxin, which blocks G-protein coupled
signaling, inhibited migration even more, indicating that other
chemokines play an additional role.
Ascites NK Cells Participate in the Immune
Response to Escherichia coli
In the context of bacterial translocation occurring in patients
with liver cirrhosis, immune cells in the peritoneal cavity
are in direct contact with intestinal bacteria and bacterial
products. Therefore, we stimulated mononuclear cells from
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FIGURE 4 | Ascites is chemotactic for NK cells. CXCL10 levels in matched ascites and blood (n = 8) (A) and results of transwell migration assays: (B) absolute
numbers of migrated cells (n = 5) (C) blood NK cells are enriched among cells migrating toward ascites (n = 5) (D) migration is dependent on CXCR3 and
G-protein-coupled signaling, with bars showing the reduction of NK cell migration compared to the respective control of PBMC migrating vs. ascites in each
experiment *p < 0.05, **p < 0.005.
ascites, blood and liver with Escherichia coli (E. coli). E.
coli stimulation led to upregulation of CD69 expression
in NK cells from all tissues (Figure 5A). In contrast,
NKG2D expression was downregulated only in ascites
NK cells (Figure 5B). Interferon-γ was produced upon
stimulation with E. coli by significant numbers of NK cells
from ascites and liver, but not from blood (Figure 5C and
Supplementary Figures 2E,F). In addition, few ascites NK cells
secreted interleukin-2 (IL-2), interleukin-10 (IL-10), tumor
necrosis factor-α (TNF-α), and granulocytes-macrophage
colony-stimulating factor (GM-CSF) in response to E.
coli (Figure 5D). We considered that E. coli stimulated
monocytes/macrophages might elicit a cytotoxic NK cell
response as described previously (11). However, only low
CD107a expression on NK cells after exposure to E. coli
stimulated monocytes/macrophages was detected (Figure 5E),
suggesting a different role for ascites NK cells. When comparing
CD56bright to CD16positive NK cells, comparable effects of
stimulation with E. coli were detected, with CD56bright NK cells
producing cytokines at higher frequency than CD16positive NK
cells (Supplementary Figures 6, 7).
Ascites NK Cells Display an Increased
Metabolic Capacity
To assess the metabolic capacity of ascites NK cells, we
measured their mitochondrial function using seahorse
technology. In this assay, selective inhibitors are
successively added and changes in oxygen consumption
are assessed. Interestingly, ascites NK cells were found
to have similar basal respiration to matched blood NK
cells, but a significantly higher spare respiratory capacity
(Figure 5F).
Interferon-γ Secretion by Ascites NK Cells
Is Dependent on Interleukin-12 and
Interleukin-18
Direct stimulation of purified NK cells with E. coli failed to
elicit an IFN-γ response (Figure 6A), suggesting that mediators
secreted by other immune cells might be required. By adding
blocking antibodies, we observed that IFN-γ secretion is
mediated mainly by IL-12 and IL-18, with IL-18 and IL-12 being
the main inducer in ascites and liver, respectively (Figures 6B,C).
We wondered whether ascites myeloid CD14positive cells might
contribute to NK cell migration and function in the peritoneal
cavity. In support of this hypothesis, ascites myeloid CD14positive
cells produced CXCL10, the ligand for CXCR3, and, after E. coli
stimulation, IL-12 (Figures 6D–F).
Ascites NK Cells Are Activated During SBP
in vivo
To ascertain that our functional ex vivo findings replicate
the situation in vivo, we analyzed NK cells in ascites samples
from cirrhosis patients with (n = 8) and without SBP (n =
15). NK cell frequency was decreased in patients with SBP
compared to patients without SBP (Figure 7A). The proportion
of CD16positive and CD56brightCD16negative NK cells did not
change during SBP (Figure 7B). While the level of CD69
expression increased on total NK cells during SBP due to higher
expression on CD16positive NK cells (Figures 7C,D), NKG2D
expression decreased on both NK cell subsets during SBP
(Figures 7E,F).
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FIGURE 5 | Response of NK cells to stimulation with E. coli and metabolic capacity of NK cells. Mononuclear cells from different tissues were stimulated with
formaldehyde-fixed Escherichia coli (E. coli) (A–E). Metabolic capacity of purified NK cells was measured by Seahorse-technology. (A) CD69 expression (n = 6–8) (B)
NKG2D expression (n = 6–12) (C) Interferon-γ production (n = 6–11) (D) Production of other cytokines/chemokines by ascites NK cells (n = 2–3) (E) CD107
expression (n = 4) (F) Mitochondrial stress assay measuring the oxygen consumption rate (OCR) of purified NK cells (n = 3 for ascites/blood; n = 1 for liver). The
drops/rises in OCR reflect the successive injection of oligomycin (1µM), FCCP (1µM), and antimycin A/rotenone (AA/Rot) (both 1µM). *p < 0.05; **p < 0.005; ***p <
0.001; BR, basal respiration; GM-CSF, granulocytes-macrophage colony-stimulating factor; IFN-γ, interferon-γ; IL, interleukin; MFI, mean fluorescence intensity; OCR,
oxygen consumption rate; oligo, oligomycin; SRC, spare respiratory capacity; TNF-α, tumor necrosis factor-α.
FIGURE 6 | E. coli-induced interferon-γ production by NK cells is mediated by cytokines secreted by CD14positive myeloid cells. Analysis of factors required for
interferon-γ response by NK cells to Escherichia coli (E. coli) and assessment of CD14positive myeloid cells as producers of relevant cytokines by flow cytometry. (A)
stimulation of purified ascites NK cells with E. coli (n = 3); effect of blocking interleukin-12 and interleukin-18 on interferon-γ production by NK cells after E. coli
stimulation of mononuclear cells from ascites (B) or liver (C) (n = 6 each) (D) gating strategy for ascites CD14positive myeloid cells (E) representative zebra plots of
CXCL10 and IL-12 staining (F) production of CXCL10 and interleukin-12 in CD14positive ascites myeloid cells (n = 5); *p < 0.05.
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FIGURE 7 | Ascites NK cell phenotype in patients with SBP. (A) NK cell frequency among lymphocytes in the ascites of patients with (n = 8) and without spontaneous
bacterial peritonitis (SBP) (n = 15) (B) Ascites NK subset distribution (C) representative zebra plots of CD69 expression (D) CD69 expression of ascites NK cells (E)
representative zebra plots of NKG2D expression on CD56bright ascites NK cells (F) NKG2D expression of ascites NK cells; *p < 0.05.
DISCUSSION
The peritoneal cavity is an immunological compartment of
particular interest. Human immune cells from the peritoneal
cavity become accessible for research when patients develop
ascites, which is common in patients with liver cirrhosis,
in patients with chronic kidney failure undergoing peritoneal
dialysis and in malignant disease such as ovarian cancer.
Studies on ascites immune cells in liver cirrhosis have been
mainly performed on the role of macrophages as primary
line of defense against invading bacteria (12–14). HLA-DR
expression on peritoneal monocytes/macrophages was found to
correlate inversely with local bacterial DNA burden, linking
ascites immune cell phenotype to bacterial translocation (2).
Concerning T lymphocytes, a decrease in the CD4/CD8 T-
cell ratio and an increase in γδ T-cells during bacterial ascites
infection have been reported (15). However, detailed reports on
ascites NK cells have been lacking so far.
In patients on peritoneal dialysis, the focus of research
has been peritoneal immunity in the context of peritonitis,
which is frequent in patients on peritoneal dialysis (16). In
these patients, a robust interferon (IFN) gamma production
by peritoneal lymphocytes seems to protect against peritonitis
by supporting antibacterial function of peritoneal macrophages
(17). More recently, Zhang and colleagues discovered that the
profile of immune cell composition and of cytokine levels in
the peritoneal cavity during peritonitis is linked to the type of
causative bacteria (18).
Concerning malignant ascites, most studies have been
performed in ovarian cancer. Because specific subsets of tumor
infiltrating lymphocytes such as cytotoxic CD8 lymphocytes or
NK cells are supposed to suppress tumor growth, Bamias and
co-authors investigated the relation between lymphocyte subsets
and tumor grade. They detected that NKT-like cells were less
frequent in the ascites from patients with cancer resistant to
chemotherapy (19). Later, NK cells were found to be enriched
in malignant ascites relative to blood, where they seemed to be
protective (20, 21). Degranulation of NK cells from ascites of
ovarian cancer patients was lower when malignant cells could be
detected, indicating not only a quantitative, but also a functional
relationship between NK cells and cancer progression (22).
These results were confirmed when NK cells were found to
be enriched and more activated in the ascites of patients with
benign andmalignant ovarian disease compared to blood, but less
activated in malignant disease compared to benign conditions
(23). This prompted a successful experimental attempt to expand
autologous NK cells from ascites of patients with ovarian cancer
and restore their activity in-vitro (24).
NK cells are well-known for their anti-viral and anti-tumor
properties, for their ability to secrete cytokines, most notably
IFN-γ, and to regulate other immune cells, such as macrophages
(25). In addition, they have been implicated in defense against
extracellular bacterial (26), for example in periodontitis (27) and
urinary tract infection (28). A relative abundance of NK cells
is known from liver, uterus and adipose tissue (29). NK cells
from these anatomic locations display a considerable diversity in
phenotype and function (29). In different experimental settings,
elimination of NK cells in murine peritonitis models led to
lower levels of inflammatory cytokines, decreased activation of
peritoneal macrophages and longer survival of mice (3, 4, 30),
but a role for human NK cells during bacterial peritonitis had
not been investigated. In humans, peritoneal NK cells from
healthy individuals are not accessible for research. However,
patients with liver cirrhosis and ascites offer the unique
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opportunity to study tissue NK cells in presence and absence
of peritonitis.
Concerning the predominant intrahepatic NK cell population,
CD56bright NK cells, we found a phenotype consistent with
previous observations (7–9, 31, 32): they constitute the majority
of liver NK cells and express Eomes, CXCR6 and CD69, but
not Tbet, CD49e or cytotoxic granules. In ascites, by contrast,
we found that CD16positive NK cells predominate, which do
not express these markers at comparable levels to CD56bright
hepatic NK cells. However, ascites NK cells displayed higher
expression levels of the chemokine receptor CXCR3 compared
to liver and blood. Correspondingly, we confirmed a previous
report that ascites contains elevated levels of the CXCR3 ligand
CXCL10 (33), and found that CXCL10 is produced by local
CD14positive myeloid cells. Trafficking of NK cells into the
peritoneal cavity via CXCR3 has been described in mice (4). In
line, comparable levels of proliferation among NK cells from all
three compartments indicated that migration may contribute to
the increased NK cells frequency in ascites. In further support
of this hypothesis, transwell experiments showed an enhanced
migration of human NK cells toward ascites compared to
plasma, which was mediated by CXCR3 and G-protein-coupled
signaling. Furthermore, ascites NK cells expressed increased
levels of CD103, whose ligand, E-cadherin, is present on human
mesothelial cells (34), facilitating transmigration of CD103positive
NK cells in the ascites. A high expression of CD103 and CXCR3
was also found in CD56bright NK cells in the ascites. The rather
similar phenotype of ascites and blood NK cells together with a
comparable frequency of CD16positive NK cells indicate that NK
cells migrate to the ascites rather from blood than from the liver.
Furthermore, ascites CD16positive NK cells differed from blood
NK cells by upregulated HLA-DR expression, indicating a higher
level of activation. We also detected a higher spare energetic
capacity, providing the energetic basis for activation. The
abundant bacterial products in the peritoneal cavity in patients
with liver cirrhosis (2, 35) might activate immune response
and induce upregulation of HLA-DR. Similarly, stimulation
of mononuclear cells with TLR ligands might explain why
NKG2D expression was downregulated in ascites (36). NKG2D
is critical for pulmonary clearance of Gram-negative infections
(37), indicating that this receptor is particularly important in the
context of NK cell immune response to bacterial infections.
In-vitro stimulation with E. coli was used as functional
assay mimicking SBP, which is the clinically most important
local complication of ascites formation in patients with liver
cirrhosis. We chose fixation of the bacteria with formaldehyde
(6) to exclude additional effects by bacterial growth. However,
this fixation method may alter the antigen structures and the
extracellular substance of the bacteria (38). In-vitro stimulation
with E. coli supported activation and modulation of NKG2D
expression of peritoneal NK cells in presence of bacteria.
Interestingly, we found that the NK cell response to bacterial
stimulation is dependent on tissue localization and cell-cell
interactions, because E. coli-induced IFN-γ secretion was not
elicited in blood NK cells and depended on IL-12 and IL-
18 in ascites. Ascites macrophages are known to be strong
producers of IL-18 upon inflammasome stimulation (39). In
addition, we detected IL-12 production in CD14positive myeloid
ascites cells. Some features of the ascites NK cells phenotype,
such as decreased NKG2D expression, would be compatible with
exhaustion after chronic stimulation (40). To further corroborate
our in-vitro findings in a clinical setting, we investigated the
phenotype of ascites NK cells in patients with and without
SBP. We found an activated phenotype in ascites NK cells
from patients with SBP, characterized by increased CD69 and
decreased NKG2D expression, indicating that NK cells take part
in the local immune response during SBP.
NK cells are considered to play a dual role during bacterial
infection and sepsis. They might be protective in an early
stage by regulating local immune response to prevent systemic
dissemination of microorganisms. At a later stage, they may
drive excessive immune activation and mortality (26). Additional
experiments demonstrating the impact of IFNγ on TNFα and
IL-6 production by CD14positive myeloid ascites suggested that
NK cells might have indeed a regulatory role during peritonitis
in patients with liver cirrhosis. A pro-inflammatory cytokine
secretion might be particularly dangerous in patients with liver
cirrhosis and SBP, who display an unbalanced immune system
similar to sepsis patients (1) and whose mortality is linked
to the degree of inflammatory response (41, 42). However, an
association of NK cell markers to clinical events in patients
with liver cirrhosis remains so far unproven. Given that our
study focused on analyzing differences between tissues, we did
not include a sufficiently high number of patients at risk for
clinical events, such as SBP and mortality, to yield statistical
power concerning clinical endpoints after correction for other
critical parameters, such as severity of liver disease and antibiotic
resistance. Still, we noted that in absence of SBP, expression
of NKG2D on ascites CD16positive NK cells was significantly
lower among the 3 patients who died within 1 year compared
to the 12 remaining patients (54% vs. 3%; p = 0.03). Follow-up
studies are needed in this respect. Another interesting question
would be to establish the phenotype of ascites NK cells from
healthy persons. However, ascites NK cells are not accessible in
healthy humans for research. In addition, in-depth mechanistic
studies elucidating the detailed processes of the immune cell
response in different tissues to bacteria are impossible in humans.
However, the outstanding achievement of this study is to
compare phenotype and function of immune cells from three
different diseased human tissues.
Although the putative both protective and detrimental role of
NK cells complicates approaches for therapeutic interventions,
the CXCR3-CXCL10 axis might constitute a promising target.
In murine peritonitis models, blockage of CXCR3 or CXCL10
in conjunction with antibiotic therapy reduced migration of NK
cells to the peritoneal cavity and improved survival, even if
applied after induction of peritonitis (4, 43, 44). An inhibitor of
CXCL10, eldelumab, has already been tested in clinical trials for
inflammatory bowel disease (45). Such a therapeutic approach
might combine the benefits of damping excessive immune
response without compromising the direct antibacterial function
of myeloid cells. Further studies on kinetics and function of
CXCR3positive lymphocytes during SBP are needed to clarify if
such an approach might be tested in clinical trials.
In summary, our findings indicate that peritoneal NK cells
are not only relevant in malignant disease, but also in patients
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with liver disease, where the constitute a locally abundant cell
population with a distinct phenotype and participate functionally
in the inflammatory response to invading bacteria. Further
research on the role of NK cells in bacterial infections in patients
with liver cirrhosis might uncover new therapeutic approaches to
prevent excessive immune response.
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